CN102250822A - Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans - Google Patents
Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans Download PDFInfo
- Publication number
- CN102250822A CN102250822A CN 201110146071 CN201110146071A CN102250822A CN 102250822 A CN102250822 A CN 102250822A CN 201110146071 CN201110146071 CN 201110146071 CN 201110146071 A CN201110146071 A CN 201110146071A CN 102250822 A CN102250822 A CN 102250822A
- Authority
- CN
- China
- Prior art keywords
- klg
- sdh
- oxydans
- genetic engineering
- sndh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000589232 Gluconobacter oxydans Species 0.000 title claims abstract description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract description 24
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 title abstract description 10
- 229930003268 Vitamin C Natural products 0.000 title abstract description 10
- 235000019154 vitamin C Nutrition 0.000 title abstract description 10
- 239000011718 vitamin C Substances 0.000 title abstract description 10
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- VBUYCZFBVCCYFD-NUNKFHFFSA-N 2-dehydro-L-idonic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-NUNKFHFFSA-N 0.000 title abstract description 4
- VBUYCZFBVCCYFD-UHFFFAOYSA-N D-arabino-2-Hexulosonic acid Natural products OCC(O)C(O)C(O)C(=O)C(O)=O VBUYCZFBVCCYFD-UHFFFAOYSA-N 0.000 title abstract description 4
- 239000002243 precursor Substances 0.000 title abstract description 3
- 241000894006 Bacteria Species 0.000 claims abstract description 29
- 238000000855 fermentation Methods 0.000 claims abstract description 25
- 230000004151 fermentation Effects 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000010353 genetic engineering Methods 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 3
- 239000013604 expression vector Substances 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000003259 recombinant expression Methods 0.000 claims description 4
- 101150098704 SDH gene Proteins 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 244000052616 bacterial pathogen Species 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 230000001590 oxidative effect Effects 0.000 claims 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 239000013605 shuttle vector Substances 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract description 11
- 239000000600 sorbitol Substances 0.000 abstract description 11
- 241000320427 Ketogulonicigenium Species 0.000 abstract description 4
- 230000009466 transformation Effects 0.000 abstract description 3
- 230000001131 transforming effect Effects 0.000 abstract description 3
- 108010020545 Sorbose dehydrogenase Proteins 0.000 abstract 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 230000004544 DNA amplification Effects 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 241000589236 Gluconobacter Species 0.000 description 2
- 241000320429 Ketogulonicigenium vulgare Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000012070 whole genome sequencing analysis Methods 0.000 description 2
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 101000864101 Gluconacetobacter liquefaciens L-sorbosone dehydrogenase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种改造氧化葡萄糖酸杆菌产维生素C前体2-酮基-L-古龙酸的方法,属于遗传工程领域。本发明通过基因工程技术,将来源于普通生酮基古龙酸菌(Ketogulonigenium vulgare)的山梨糖脱氢酶(SDH)、山梨酮脱氢酶(SNDH)基因表达于氧化葡萄糖酸杆菌(Gluconobacter oxydans)中,获得了一株利用山梨醇生产2-KLG的G.oxydans工程菌。G.oxydans是二步发酵法生产2-KLG中第一步发酵过程常用菌种,将sdh、sndh基因表达于G.oxydans中,可以解除小菌对伴生菌依赖的问题,实现了从D-山梨醇到2-KLG的直接转化,简化了维生素C生产工艺,2-KLG的产量可达83g/L,具有很好的应用前景。The invention discloses a method for transforming gluconobacterium oxydans to produce vitamin C precursor 2-keto-L-gulonic acid, which belongs to the field of genetic engineering. The present invention expresses the genes of sorbose dehydrogenase (SDH) and sorbone dehydrogenase (SNDH) derived from Ketogulonigenium vulgare in Gluconobacter oxydans through genetic engineering technology In this study, a strain of G.oxydans engineered strain that utilizes sorbitol to produce 2-KLG was obtained. G.oxydans is a commonly used strain in the first step of the fermentation process in the production of 2-KLG by the two-step fermentation method. Expressing the sdh and sndh genes in G.oxydans can relieve the problem of the dependence of the small bacteria on the accompanying bacteria and realize the transformation from D- The direct conversion of sorbitol to 2-KLG simplifies the production process of vitamin C, and the output of 2-KLG can reach 83g/L, which has a good application prospect.
Description
技术领域 technical field
本发明涉及一种高产2-KLG的氧化葡萄糖酸杆菌工程菌及其构建方法,采用分子手段引入SDH、SNDH,从而实现代谢山梨醇生产2-KLG,属于遗传工程领域。The invention relates to a high-yielding 2-KLG gluconobacter oxidase engineering bacterium and a construction method thereof, which adopts molecular means to introduce SDH and SNDH to realize the production of 2-KLG by metabolizing sorbitol, and belongs to the field of genetic engineering.
背景技术 Background technique
维生素C(Vitamin C,VC),又称为抗坏血酸(Ascorbic acid),是一种人体必需的维生素和抗氧化剂,广泛应用于医药、食品、饲料和化妆品等工业。目前国内维生素C工业化生产采用二步发酵法,在第二步混合菌发酵体系中,执行糖酸转化的微生物只有小菌,小菌单独生长很困难,需要与大菌共同培养才能正常生长。两种菌的发酵控制为生产工艺增加了很大困难,且小菌产酸性状不稳定,因而导致生产不稳定,经常因菌种退化造成倒罐,导致生产上屡屡遭受重大损失。我国维生素C发酵技术从山梨醇到2-KLG的发酵过程由3种细菌参与,势必在微生物代谢过程中造成底物和培养基的大量浪费,发酵过程分为两步不但延长了生产周期还造成能源和人力的大量浪费。因此,现有维生素C两步发酵工艺尚存在巨大技术进步的潜力。如何简化发酵工艺是一个迫切需要解决的问题。Vitamin C (Vitamin C, VC), also known as Ascorbic acid (Ascorbic acid), is an essential vitamin and antioxidant, widely used in industries such as medicine, food, feed and cosmetics. At present, the industrial production of vitamin C in China adopts a two-step fermentation method. In the second-step mixed-bacteria fermentation system, only small bacteria perform sugar-acid conversion. It is difficult for small bacteria to grow alone, and they need to be co-cultured with large bacteria to grow normally. The fermentation control of the two kinds of bacteria has added great difficulties to the production process, and the acid-producing properties of the small bacteria are unstable, resulting in unstable production, and the tanks are often inverted due to the degradation of the bacteria, resulting in repeated heavy losses in production. The fermentation process of my country's vitamin C fermentation technology from sorbitol to 2-KLG involves three kinds of bacteria, which will inevitably cause a lot of waste of substrate and medium in the process of microbial metabolism. The fermentation process is divided into two steps, which not only prolongs the production cycle but also causes A huge waste of energy and manpower. Therefore, the existing vitamin C two-step fermentation process still has great potential for technological progress. How to simplify the fermentation process is an urgent problem to be solved.
发明内容 Contents of the invention
本发明的目的是提供一种高产2-KLG的G.oxydans工程菌。The purpose of the present invention is to provide a high-yielding 2-KLG G.oxydans engineering bacteria.
所述工程菌可表达sdh、sndh基因。The engineering bacteria can express sdh and sndh genes.
所述sdh、sndh基因核苷酸序列分别如SEQ ID NO.1和SEQ ID NO.2所示。The nucleotide sequences of the sdh and sndh genes are shown in SEQ ID NO.1 and SEQ ID NO.2 respectively.
所述sdh、sndh基因克隆于G.oxydans-E.coli穿梭质粒载体pGUC1上。The sdh and sndh genes are cloned on the G.oxydans-E.coli shuttle plasmid vector pGUC1.
本发明要解决的另一个技术问题是提供一种高产2-KLG的G.oxydans基因工程菌的构建方法。Another technical problem to be solved by the present invention is to provide a method for constructing a high-yield 2-KLG G.oxydans genetically engineered bacterium.
为解决上述技术问题,本发明的具体方案为:In order to solve the problems of the technologies described above, the specific solutions of the present invention are:
1)根据本实验室对K.vulgare DSM 4205的全基因组测序结果中注释的sdh、sndh基因序列设计引物克隆sdh、sndh基因;1) Design primers to clone sdh and sndh genes according to the sdh and sndh gene sequences annotated in the whole genome sequencing results of K.vulgare DSM 4205 in our laboratory;
2)将sdh、sndh基因与载体连接得到重组表达载体;2) connecting the sdh and sndh genes with the vector to obtain a recombinant expression vector;
3)将得到的重组表达载体转化氧化葡萄糖酸杆菌(Gluconobacter oxydans,ATCC 621H)后得到重组菌株。3) Transform the obtained recombinant expression vector into Gluconobacter oxydans (Gluconobacter oxydans, ATCC 621H) to obtain a recombinant strain.
本发明要解决的另一个技术问题是提供一种发酵生产2-KLG的方法,工程菌种子培养后,按15%比例接种5L发酵罐,发酵16h后,流加量碳源2.5g/L.h,发酵参数:转速500rpm,pH 5.1~5.4,通气量1.5vvm,控制罐温34℃,罐压0.05MPa。Another technical problem to be solved by the present invention is to provide a method for fermenting and producing 2-KLG. After the engineered bacteria seeds are cultivated, a 5L fermenter is inoculated at a ratio of 15%, and after 16 hours of fermentation, the feed-in carbon source is 2.5g/L.h. Fermentation parameters: speed 500rpm, pH 5.1~5.4, ventilation 1.5vvm, control tank temperature 34°C, tank pressure 0.05MPa.
种子和斜面培养基(g/L):山梨醇15,酵母膏0.6,碳酸钙0.4,pH 4.8~5.1,琼脂20(斜面培养基),pH 7.0,121℃灭菌15min,氨苄青霉素终浓度100μg/mL。Seed and slant medium (g/L): sorbitol 15, yeast extract 0.6, calcium carbonate 0.4, pH 4.8-5.1, agar 20 (slant medium), pH 7.0, sterilized at 121°C for 15 minutes, final concentration of ampicillin 100 μg /mL.
发酵培养基(g/L):山梨醇25,酵母膏0.2,碳酸钙0.2,初始pH 5.1~5.4,121℃灭菌15min,氨苄青霉素终浓度100μg/mL。Fermentation medium (g/L): sorbitol 25, yeast extract 0.2, calcium carbonate 0.2, initial pH 5.1-5.4, sterilized at 121°C for 15 minutes, final concentration of ampicillin 100 μg/mL.
山梨醇、2-KLG含量测定:液相色谱(LC)Determination of sorbitol and 2-KLG content: liquid chromatography (LC)
发酵样品用流动相十倍稀释,0.45μm滤膜过滤。Agilent 1100system,RioRad公司Aminex HPX-87H色谱柱;流动相:2.75μmol/L浓硫酸;柱温:35℃;流速:0.6mL/min;进样量:5μL;检测器:示差折光检测器。Fermentation samples were diluted tenfold with mobile phase and filtered through a 0.45 μm filter membrane. Agilent 1100system, RioRad Aminex HPX-87H chromatographic column; mobile phase: 2.75 μmol/L concentrated sulfuric acid; column temperature: 35°C; flow rate: 0.6mL/min; injection volume: 5 μL; detector: differential refractive index detector.
本发明通过基因工程改造,将来源于普通生酮基古龙酸菌(Ketogulonigenium vulgare)的sdh、sndh基因表达于氧化葡萄糖酸杆菌(Gluconobacter oxydans)中,获得了一株利用山梨醇生产2-KLG的G.oxydans工程菌。采用G.oxydans工程菌利用山梨醇一步发酵生产2-KLG,解除了小菌对伴生菌依赖的问题,简化了维生素C生产工艺。2-KLG的产量可达83g/L,具有很好的应用前景。本发明提供的构建方法简单,适于标准化。The present invention expresses the sdh and sndh genes derived from Ketogulonigenium vulgare in Gluconobacter oxydans through genetic engineering transformation, and obtains a strain that utilizes sorbitol to produce 2-KLG G.oxydans engineering bacteria. G.oxydans engineering bacteria are used to produce 2-KLG by one-step fermentation of sorbitol, which solves the problem of the dependence of small bacteria on accompanying bacteria and simplifies the production process of vitamin C. The output of 2-KLG can reach 83g/L, which has a good application prospect. The construction method provided by the invention is simple and suitable for standardization.
具体实施方式 Detailed ways
实施例1表达载体的构建The construction of embodiment 1 expression vector
设计引物P1:5’GGAATTCCATATGATGAAACCGACTTCGCTGCTTTGGGC3’;P2:5’CGCGGATCCTTATTGCGGCAGGGCGAAGACGTAGA3’,克隆K.vulgareDSM4205的sdh基因序列扩增后克隆到G.oxydans-E.coli穿梭质粒载体pGUC1上,构建表达载体pGUC1-sdh,将构建好的表达载体转化大肠杆菌JM109后,挑选转化子,提取质粒并经NdeI及BamHI酶切后,出现1740bp的条带,证明已经成功构建表达载体pGUC1-sdh。设计引物P3:5’CGCGGATCCATGTTACCCAAATCATTGAAACATAAGA3’;P4:5’CGAGCTCTCAGCGGG TGGCAGCGG3’,再将本实验室对K.vulgare DSM4205的全基因组测序结果中注释的sndh基因序列扩增后克隆到穿梭质粒载体pGUC1上,构建表达载体pGUC1-sdh-sndh,将构建好的表达载体转化大肠杆菌JM109后,挑选转化子,提取质粒并经BamHI及SacI酶切后,出现1830bp的条带,证明已经成功构建表达载体pGUC1-sdh-sldh。Design primers P1: 5'GGAATTCCATATGATGAAACCGACTTCGCTGCTTTGGGC3'; P2: 5'CGCGGATCCTTATTGCGGCAGGGCGAAGACGTAGA3', clone the sdh gene sequence of K.vulgareDSM4205 after amplification and clone it into the G.oxydans-E.coli shuttle plasmid vector pGUC1, and construct the expression vector pGUC1-sdh. After the constructed expression vector was transformed into Escherichia coli JM109, the transformants were selected, the plasmid was extracted and digested with NdeI and BamHI, a 1740bp band appeared, which proved that the expression vector pGUC1-sdh had been successfully constructed. Primers P3: 5'CGCGGATCCATGTTACCCAAATCATTGAAACATAAGA3'; P4: 5'CGAGCTCTCAGCGGG TGGCAGCGG3' were designed, and the sndh gene sequence annotated in the whole genome sequencing results of K. vulgare DSM4205 in our laboratory was amplified and cloned into the shuttle plasmid vector pGUC1 to construct The expression vector pGUC1-sdh-sndh, after transforming the constructed expression vector into Escherichia coli JM109, selecting the transformant, extracting the plasmid and digesting it with BamHI and SacI, a 1830bp band appeared, proving that the expression vector pGUC1-sdh has been successfully constructed -sldh.
实施例2G.oxydans工程菌的构建The construction of embodiment 2G.oxydans engineering bacteria
将构建好的表达载体转化E.coli JM109。由于重组质粒上带有氨苄青霉素抗性基因,转化E.coli JM109感受态,涂布到含有氨苄青霉素的LB(酵母膏5g/L,蛋白胨10g/L,NaCl 10g/L,固体培养基加20g/L琼脂,调节pH 7.0,121℃灭菌15min),挑取转化后平板上正常生长的转化子,提取质粒PCR验证,分别出现1740bp、1830bp的条带,对照未能PCR出同样条带,证明已成功转化到E.coli中,再将提取的质粒转化G.oxydans,得到G.oxydans-pGUC1-sdh-sndh工程菌。Transform the constructed expression vector into E.coli JM109. Since the recombinant plasmid carries the ampicillin resistance gene, transform E.coli JM109 competent, apply to LB containing ampicillin (yeast extract 5g/L, peptone 10g/L, NaCl 10g/L, solid medium plus 20g /L agar, adjust the pH to 7.0, and sterilize at 121°C for 15 minutes), pick the transformants that grow normally on the plate after transformation, and extract the plasmids for PCR verification. Bands of 1740bp and 1830bp appear respectively, and the same bands cannot be obtained by PCR in the control. It is proved that it has been successfully transformed into E.coli, and then the extracted plasmid is transformed into G.oxydans to obtain G.oxydans-pGUC1-sdh-sndh engineering bacteria.
实施例3发酵生产2-KLGEmbodiment 3 fermentation produces 2-KLG
种子和斜面培养基(g/L):山梨醇20,酵母膏2,碳酸钙0.4,pH 4.8~5.1,琼脂20(斜面培养基),pH 7.0,121℃灭菌15min,氨苄青霉素终浓度100μg/mL。Seed and slant medium (g/L): sorbitol 20, yeast extract 2, calcium carbonate 0.4, pH 4.8-5.1, agar 20 (slant medium), pH 7.0, sterilized at 121°C for 15 minutes, final concentration of ampicillin 100 μg /mL.
发酵培养基(g/L):山梨醇80,酵母膏5,碳酸钙0.2,初始pH 5.1~5.4,121℃灭菌15min,氨苄青霉素终浓度100μg/mL。Fermentation medium (g/L): sorbitol 80, yeast extract 5, calcium carbonate 0.2, initial pH 5.1-5.4, sterilized at 121°C for 15 minutes, final concentration of ampicillin 100 μg/mL.
培养条件:从斜面中接种重组菌于20mL的种子培养基中,30℃、200rpm培养32h后接15%于发酵培养基,于34℃、220rpm进行摇瓶发酵,发酵周期48h。2-KLG产量为52g/L。Culture conditions: inoculate the recombinant bacteria from the slant into 20mL seed medium, culture at 30°C and 200rpm for 32h, then add 15% to the fermentation medium, and carry out shake flask fermentation at 34°C and 220rpm, and the fermentation period is 48h. The yield of 2-KLG was 52g/L.
实施例4发酵生产2-KLGEmbodiment 4 fermentation produces 2-KLG
工程菌种子培养后,按15%比例接种5L发酵罐,发酵16h后流加量碳源2.5g/L.h,发酵参数:转速500rpm,pH 5.1~5.4,通气量1.5vvm,控制罐温34℃,罐压0.05MPa,发酵结束后2-KLG产量达到83g/L。After culturing the engineered bacteria seeds, inoculate a 5L fermenter at a ratio of 15%. After 16 hours of fermentation, the amount of carbon source is 2.5g/L.h. The tank pressure is 0.05MPa, and the 2-KLG yield reaches 83g/L after fermentation.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Any person familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore The scope of protection of the present invention should be defined by the claims.
序列表sequence listing
<110> 江南大学 <110> Jiangnan University
the
<110> 江南大学 <110> Jiangnan University
the
<120> 一种改造氧化葡萄糖酸杆菌产维生素C前体2-酮基-L-古龙酸的方法 <120> A method for transforming Gluconobacter oxidans to produce vitamin C precursor 2-keto-L-gulonic acid
the
<160> 9 <160> 9
the
<170> PatentIn version 3.3 <170> PatentIn version 3.3
the
<210> 1 <210> 1
<211> 1740 <211> 1740
<212> DNA <212> DNA
<213> 普通生酮基古龙酸菌(Ketogulonigenium vulgareDSM4205) <213> Ketogulonigenium vulgare DSM4205
the
<400> 1 <400> 1
atgaaaccga cttcgctgct ttgggccagt gctggcgcac ttgcattgct tgccgcaccc 60 atgaaaccga cttcgctgct ttgggccagt gctggcgcac ttgcattgct tgccgcaccc 60
gcctttgctc aagtgacccc cgtcaccgat gaattgctgg cgaacccgcc cgctggtgaa 120 gcctttgctc aagtgacccc cgtcaccgat gaattgctgg cgaacccgcc cgctggtgaa 120
tggatcagct acggtcagaa ccaagaaaac taccgtcact cgcccctgac gcagatcacg 180 tggatcagct acggtcagaa ccaagaaaac taccgtcact cgcccctgac gcagatcacg 180
actgagaacg tcggccaact gcaactggtc tgggcgcgcg gcatgcagcc gggcaaagtc 240 actgagaacg tcggccaact gcaactggtc tgggcgcgcg gcatgcagcc gggcaaagtc 240
caagtcacgc ccctgatcca tgacggcgtc atgtatctgg caaacccggg cgacgtgatc 300 caagtcacgc ccctgatcca tgacggcgtc atgtatctgg caaacccggg cgacgtgatc 300
caggccatcg acgccaaaac tggcgatctg atctgggaac accgccgcca actgccgaac 360 caggccatcg acgccaaaac tggcgatctg atctgggaac accgccgcca actgccgaac 360
atcgccacgc tgaacagctt tggcgagccg acccgcggca tggcgctgta cggcaccaac 420 atcgccacgc tgaacagctt tggcgagccg acccgcggca tggcgctgta cggcaccaac 420
gtttactttg tttcgtggga caaccacctg gtcgccctcg acaccgcaac tggccaagtg 480 gtttactttg tttcgtggga caaccacctg gtcgccctcg acaccgcaac tggccaagtg 480
acgttcgacg tcgaccgcgg ccaaggcgaa gacatggttt cgaactcgtc gggcccgatc 540 acgttcgacg tcgaccgcgg ccaaggcgaa gacatggttt cgaactcgtc gggcccgatc 540
gtggcaaacg gcgtgatcgt tgccggttcg acctgccaat actcgccgtt cggctgcttt 600 gtggcaaacg gcgtgatcgt tgccggttcg acctgccaat actcgccgtt cggctgcttt 600
gtctcgggcc acgactcggc caccggtgaa gagctgtggc gcaactactt catcccgcgc 660 gtctcgggcc acgactcggc caccggtgaa gagctgtggc gcaactactt catcccgcgc 660
gctggcgaag agggtgatga gacttggggc aacgattacg aagcccgttg gatgaccggt 720 gctggcgaag agggtgatga gacttggggc aacgattacg aagcccgttg gatgaccggt 720
gcctggggcc agatcaccta tgaccccgtc accaaccttg tccactacgg ctcgaccgct 780 gcctggggcc agatcaccta tgaccccgtc accaaccttg tccactacgg ctcgaccgct 780
gtgggtccgg cgtcggaaac ccaacgcggc accccgggcg gcacgctgta cggcacgaac 840 gtgggtccgg cgtcggaaac ccaacgcggc accccgggcg gcacgctgta cggcacgaac 840
acccgtttcg ccgtgcgtcc tgacacgggc gagattgtct ggcgtcacca gaccctgccc 900 acccgtttcg ccgtgcgtcc tgacacgggc gagattgtct ggcgtcacca gaccctgccc 900
cgcgacaact gggaccagga atgcacgttc gagatgatgg tcaccaatgt ggatgtccaa 960 cgcgacaact gggaccagga atgcacgttc gagatgatgg tcaccaatgt ggatgtccaa 960
ccctcgaccg agatggaagg tctgcagtcg atcaacccga acgccgcaac tggcgagcgt 1020 ccctcgaccg agatggaagg tctgcagtcg atcaacccga acgccgcaac tggcgagcgt 1020
cgcgtgctga ccggcgttcc gtgcaaaacc ggcaccatgt ggcagttcga cgccgaaacc 1080 cgcgtgctga ccggcgttcc gtgcaaaacc ggcaccatgt ggcagttcga cgccgaaacc 1080
ggcgaattcc tgtgggcccg tgataccaac taccagaaca tgatcgaatc catcgacgaa 1140 ggcgaattcc tgtgggcccg tgataccaac taccagaaca tgatcgaatc catcgacgaa 1140
aacggcatcg tgaccgtgaa cgaagatgcg atcctgaagg aactggatgt tgaatatgac 1200 aacggcatcg tgaccgtgaa cgaagatgcg atcctgaagg aactggatgt tgaatatgac 1200
gtctgcccga ccttcttggg cggccgcgac tggccgtcgg ccgcactgaa ccccgacagc 1260 gtctgcccga ccttcttggg cggccgcgac tggccgtcgg ccgcactgaa ccccgacagc 1260
ggcatctact tcatcccgct gaacaacgtc tgctatgaca tgatggccgt cgatcaggaa 1320 ggcatctact tcatcccgct gaacaacgtc tgctatgaca tgatggccgt cgatcaggaa 1320
ttcacctcga tggacgtcta taacaccagc aacgtgacca agctgccgcc cggcaaggat 1380 ttcacctcga tggacgtcta taacaccagc aacgtgacca agctgccgcc cggcaaggat 1380
atgatcggtc gtattgacgc gatcgacatc agcacgggtc gtacgctgtg gtcggtcgaa 1440 atgatcggtc gtattgacgc gatcgacatc agcacgggtc gtacgctgtg gtcggtcgaa 1440
cgtgctgcgg cgaactattc gcccgtcttg tcgaccggcg gcggcgttct gttcaacggt 1500 cgtgctgcgg cgaactattc gcccgtcttg tcgaccggcg gcggcgttct gttcaacggt 1500
ggtacggatc gttacttccg cgccctcagc caagaaaccg gcgagaccct gtggcagacc 1560 ggtacggatc gttacttccg cgccctcagc caagaaaccg gcgagaccct gtggcagacc 1560
cgccttgcaa ccgtcgcgtc gggccaggcc atctcttacg aggttgacgg catgcaatat 1620 cgccttgcaa ccgtcgcgtc gggccaggcc atctcttacg aggttgacgg catgcaatat 1620
gtcgccatcg caggtggtgg tgtcagctat ggctcgggcc tgaactcggc actggctggc 1680 gtcgccatcg caggtggtgg tgtcagctat ggctcgggcc tgaactcggc actggctggc 1680
gagcgagtcg actcgaccgc catcggtaac gccgtctacg tcttcgccct gccgcaataa 1740 gagcgagtcg actcgaccgc catcggtaac gccgtctacg tcttcgccct gccgcaataa 1740
the
the
<210> 2 <210> 2
<211> 1830 <211> 1830
<212> DNA <212> DNA
<213> 普通生酮基古龙酸菌(Ketogulonigenium vulgareDSM4205) <213> Ketogulonigenium vulgare DSM4205
the
<400> 2 <400> 2
atgttaccca aatcattgaa acataagaat ggcgccatgc gccttgtcgc agcctcgacc 60 atgttaccca aatcattgaa acataagaat ggcgccatgc gccttgtcgc agcctcgacc 60
cttgcgctga tgatcggcgc gggtgcccat gcgcaggtaa acccggtcga agtgccggtg 120 cttgcgctga tgatcggcgc gggtgcccat gcgcaggtaa acccggtcga agtgccggtg 120
ggcgcgaacg agacctttac ctcgcgcgtg ctgaccaccg gcctgtcgaa cccttgggaa 180 ggcgcgaacg agacctttac ctcgcgcgtg ctgaccaccg gcctgtcgaa cccttgggaa 180
atcacctggg gccccgacaa tatgctgtgg gtgaccgagc gatcttccgg cgaagtgacg 240 atcacctggg gccccgacaa tatgctgtgg gtgaccgagc gatcttccgg cgaagtgacg 240
cgcgtcgacc ccaataccgg cgagcagcag gtcctgctga ccctgaccga tttcagcgtc 300 cgcgtcgacc ccaataccgg cgagcagcag gtcctgctga ccctgaccga tttcagcgtc 300
gatgtgcaac accagggcct acttggcctc gcgctgcatc ctgagtttat gcaagagagc 360 gatgtgcaac accagggcct acttggcctc gcgctgcatc ctgagtttat gcaagagagc 360
ggcaacgact acgtctatat cgtctacact tataacaccg gcaccgaaga agcgcccgat 420 ggcaacgact acgtctatat cgtctacact tataacaccg gcaccgaaga agcgcccgat 420
ccgcatcaaa agctggtgcg ttatgcctat gacgctgccg cgcagcagct ggtcgatccg 480 ccgcatcaaa agctggtgcg ttatgcctat gacgctgccg cgcagcagct ggtcgatccg 480
gttgatctgg tcgcaggcat tcccgcaggc aacgaccaca atggcggtcg catcaaattc 540 gttgatctgg tcgcaggcat tcccgcaggc aacgaccaca atggcggtcg catcaaattc 540
gcccccgatg gccaacacat cttttacacg ctgggcgagc aaggcgcgaa ctttggcggt 600 gcccccgatg gccaacacat cttttacacg ctgggcgagc aaggcgcgaa ctttggcggt 600
aacttccgcc gtccgaacca cgcgcaactg ctgccgacgc aagagcaggt cgacgcgggc 660 aacttccgcc gtccgaacca cgcgcaactg ctgccgacgc aagagcaggt cgacgcgggc 660
gattgggtcg cctattcggg caagatcctg cgcgtgaacc ttgacggcac gatccccgaa 720 gattgggtcg cctattcggg caagatcctg cgcgtgaacc ttgacggcac gatccccgaa 720
gacaaccccg agatcgaggg cgtgcgtagc catatcttta cctatggcca ccgtaacccg 780 gacaaccccg agatcgaggg cgtgcgtagc catatcttta cctatggcca ccgtaacccg 780
cagggcatca cctttggccc cgacggcacc atttatgcca ccgaacacgg ccccgatacg 840 cagggcatca cctttggccc cgacggcacc atttatgcca ccgaacacgg ccccgatacg 840
gatgacgagc tgaacatcat cgccggcggt ggcaactatg ggtggccgaa tgtggccggc 900 gatgacgagc tgaacatcat cgccggcggt ggcaactatg ggtggccgaa tgtggccggc 900
tatcgcgatg gcaaatccta tgtctacgct gattggagcc aagcgcccgc tgaccagcgt 960 tatcgcgatg gcaaatccta tgtctacgct gattggagcc aagcgcccgc tgaccagcgt 960
tacaccggtc gcgccggtat ccccgacacc gtgccgcaat tccccgagct ggaattcgcg 1020 tacaccggtc gcgccggtat ccccgacacc gtgccgcaat tccccgagct ggaattcgcg 1020
cccgagatgg tcgatccgct gacaacctat tggacggtgg ataatgatta cgatttcacc 1080 cccgagatgg tcgatccgct gacaacctat tggacggtgg ataatgatta cgatttcacc 1080
gccaattgcg gctggatctg taatccgacg atcgcgcctt cgtctgccta ttactatgcg 1140 gccaattgcg gctggatctg taatccgacg atcgcgcctt cgtctgccta ttactatgcg 1140
gcgggcgaga gcggtatcgc ggcttgggat aattcgatcc tgatcccgac gctgaaacat 1200 gcgggcgaga gcggtatcgc ggcttgggat aattcgatcc tgatcccgac gctgaaacat 1200
ggcggcatct atgtgcagca cctcagcgat gatggccaat ctgtcgacgg cctgcccgag 1260 ggcggcatct atgtgcagca cctcagcgat gatggccaat ctgtcgacgg cctgcccgag 1260
ctgtggttca gcacccagaa ccgctatcgc gatatcgaga tcagccccga taaccatgtt 1320 ctgtggttca gcacccagaa ccgctatcgc gatatcgaga tcagccccga taaccatgtt 1320
tttgtggcga ccgacaactt tggcacctcg gcgcagaaat atggcgagac cggctttacc 1380 tttgtggcga ccgacaactt tggcacctcg gcgcagaaat atggcgagac cggctttacc 1380
aacgtgctgc ataaccccgg cgcgatcctt gtctttagct atgtcggcga ggatgctgcg 1440 aacgtgctgc ataaccccgg cgcgatcctt gtctttagct atgtcggcga ggatgctgcg 1440
ggtcagaccg gaatgatgac cgcgcccgca ccgcagacgc aatacacgca agtgcccgcc 1500 ggtcagaccg gaatgatgac cgcgcccgca ccgcagacgc aatacacgca agtgcccgcc 1500
gagggtgcag gcgcgggcgc gactgaggtt gcggatgtcg attacgacac gctgttcacc 1560 gagggtgcag gcgcgggcgc gactgaggtt gcggatgtcg attacgacac gctgttcacc 1560
gaaggccaga ccctttatgg cagcgcatgt gccgcgtgcc atggtgccgc tggccaaggt 1620 gaaggccaga ccctttatgg cagcgcatgt gccgcgtgcc atggtgccgc tggccaaggt 1620
gcgcagggcc cgacctttgt gggcgtgccg gatgtgacgg gtgacaagga ctaccttgcc 1680 gcgcagggcc cgacctttgt gggcgtgccg gatgtgacgg gtgacaagga ctaccttgcc 1680
cgcaccatca tccacggttt tggctatatg ccgtcgtttg cgactcggct ggatgacgag 1740 cgcaccatca tccacggttt tggctatatg ccgtcgtttg cgactcggct ggatgacgag 1740
gaggttgccg ccatcgcgac ctttatccgc aacagctggg gcaatgacga aggcatcctg 1800 gaggttgccg ccatcgcgac ctttatccgc aacagctggg gcaatgacga aggcatcctg 1800
accccggccg aggccgctgc cacccgctga 1830 accccggccg aggccgctgc cacccgctga 1830
the
<210> 3 <210> 3
<211> 39 <211> 39
<212> DNA <212> DNA
<213> 人工合成序列 <213> Synthetic sequences
the
<220> <220>
<223> 根据基因序列设计,用于基因扩增。 <223> Designed according to gene sequence for gene amplification.
the
<400> 3 <400> 3
ggaattccat atgatgaaac cgacttcgct gctttgggc 39 ggaattccat atgatgaaac cgacttcgct gctttgggc 39
the
<210> 4 <210> 4
<211> 35 <211> 35
<212> DNA <212> DNA
<213> 人工合成序列 <213> Synthetic sequences
the
<220> <220>
<223> 根据基因序列设计,用于基因扩增。 <223> Designed according to gene sequence for gene amplification.
the
<400> 4 <400> 4
cgcggatcct tattgcggca gggcgaagac gtaga 35 cgcggatcct tattgcggca gggcgaagac gtaga 35
the
<210> 5 <210> 5
<211> 37 <211> 37
<212> DNA <212> DNA
<213> 人工合成序列 <213> Synthetic sequences
the
<220> <220>
<223> 根据基因序列设计,用于基因扩增。 <223> Designed according to gene sequence for gene amplification.
the
<400> 5 <400> 5
cgcggatcca tgttacccaa atcattgaaa cataaga 37 cgcggatcca tgttacccaa atcattgaaa cataaga 37
the
<210> 6 <210> 6
<211> 24 <211> 24
<212> DNA <212> DNA
<213> 人工合成序列 <213> Synthetic sequences
the
<220> <220>
<223> 根据基因序列设计,用于基因扩增。 <223> Designed according to gene sequence for gene amplification.
the
<400> 6 <400> 6
cgagctctca gcgggtggca gcgg 24 cgagctctca gcgggtggca gcgg 24
the
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110146071 CN102250822A (en) | 2011-06-01 | 2011-06-01 | Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110146071 CN102250822A (en) | 2011-06-01 | 2011-06-01 | Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102250822A true CN102250822A (en) | 2011-11-23 |
Family
ID=44978394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110146071 Pending CN102250822A (en) | 2011-06-01 | 2011-06-01 | Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102250822A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102492762A (en) * | 2011-12-09 | 2012-06-13 | 天津大学 | Application of Gluconobacter oxydans containing sorbosone dehydrogenase gene encoding carrier |
CN102653767A (en) * | 2012-05-26 | 2012-09-05 | 江南大学 | Novel gene for L-sorbose/L-sorbosone dehydrogenase and application of novel gene |
CN102676552A (en) * | 2012-05-25 | 2012-09-19 | 江南大学 | Novel L-sorbosone dehydrogenase gene and application thereof |
CN102816780A (en) * | 2012-09-07 | 2012-12-12 | 天津大学 | Combination gene of gene cluster ABCDEN by synthesizing sorbose dehydrogenase genes, sorbosone dehydrogenase genes and pyrroloquinoline quinone |
CN102851252A (en) * | 2012-08-03 | 2013-01-02 | 江南大学 | Gluconobacter oxydans engineering bacterium for producing sorbic ketone in high yield mode and construction method thereof |
CN103484417A (en) * | 2013-10-08 | 2014-01-01 | 江南大学 | Gluconobacter oxydans improving 2-KLG fermentation yield and application thereof |
CN103484418A (en) * | 2013-10-08 | 2014-01-01 | 江南大学 | Gluconobacter oxydans gene engineering bacteria for producing 2-KLG and its application |
CN104357347A (en) * | 2014-09-23 | 2015-02-18 | 虞龙 | Gluconobacter oxydans and application of gluconobacter oxydans in production of VC precursor by fermentation |
CN104673736A (en) * | 2015-03-11 | 2015-06-03 | 江南大学 | Method for improving gluconobacter oxydans for producing 2-keto-L-gulconic acid |
CN105420222A (en) * | 2015-12-04 | 2016-03-23 | 帝斯曼江山制药(江苏)有限公司 | Mutation screening method of ketogulonigenium vulgare |
CN109234350A (en) * | 2018-11-15 | 2019-01-18 | 江南大学 | A kind of method of fermenting and producing vitamin C precursor 2-keto-L-gulonic acid |
CN114480237A (en) * | 2022-02-23 | 2022-05-13 | 江南大学 | Two-stage fermentation method for increasing yield of 2-KLG in gluconobacter |
CN114480236A (en) * | 2022-02-23 | 2022-05-13 | 江南大学 | A kind of construction method of Gluconobacter one-step bacteria chassis cell bank producing 2-KLG |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101402988A (en) * | 2008-11-07 | 2009-04-08 | 江南大学 | High-efficiency method for accelerating synthesis of 2-keto-L-gulonic acid with additive metal ion |
-
2011
- 2011-06-01 CN CN 201110146071 patent/CN102250822A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101402988A (en) * | 2008-11-07 | 2009-04-08 | 江南大学 | High-efficiency method for accelerating synthesis of 2-keto-L-gulonic acid with additive metal ion |
Non-Patent Citations (3)
Title |
---|
《Genbank》 20061003 Tomiyama,N. 登录号AB092515.1 全文 3 , * |
《Genbank》 20070424 Yang,X.P. 登录号EF493853.1 全文 2 , * |
《中国食品添加剂》 20030630 仪宏,张华峰 维生素C生产技术 78 第6卷, * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102492762A (en) * | 2011-12-09 | 2012-06-13 | 天津大学 | Application of Gluconobacter oxydans containing sorbosone dehydrogenase gene encoding carrier |
CN102676552A (en) * | 2012-05-25 | 2012-09-19 | 江南大学 | Novel L-sorbosone dehydrogenase gene and application thereof |
CN102653767A (en) * | 2012-05-26 | 2012-09-05 | 江南大学 | Novel gene for L-sorbose/L-sorbosone dehydrogenase and application of novel gene |
CN102851252A (en) * | 2012-08-03 | 2013-01-02 | 江南大学 | Gluconobacter oxydans engineering bacterium for producing sorbic ketone in high yield mode and construction method thereof |
CN102851252B (en) * | 2012-08-03 | 2014-11-26 | 江南大学 | Gluconobacter oxydans engineering bacterium for producing sorbic ketone in high yield mode and construction method thereof |
CN102816780A (en) * | 2012-09-07 | 2012-12-12 | 天津大学 | Combination gene of gene cluster ABCDEN by synthesizing sorbose dehydrogenase genes, sorbosone dehydrogenase genes and pyrroloquinoline quinone |
CN103484417B (en) * | 2013-10-08 | 2015-06-24 | 江南大学 | Gluconobacter oxydans improving 2-KLG fermentation yield and application thereof |
CN103484417A (en) * | 2013-10-08 | 2014-01-01 | 江南大学 | Gluconobacter oxydans improving 2-KLG fermentation yield and application thereof |
CN103484418A (en) * | 2013-10-08 | 2014-01-01 | 江南大学 | Gluconobacter oxydans gene engineering bacteria for producing 2-KLG and its application |
CN104357347A (en) * | 2014-09-23 | 2015-02-18 | 虞龙 | Gluconobacter oxydans and application of gluconobacter oxydans in production of VC precursor by fermentation |
CN104673736A (en) * | 2015-03-11 | 2015-06-03 | 江南大学 | Method for improving gluconobacter oxydans for producing 2-keto-L-gulconic acid |
CN105420222A (en) * | 2015-12-04 | 2016-03-23 | 帝斯曼江山制药(江苏)有限公司 | Mutation screening method of ketogulonigenium vulgare |
CN109234350A (en) * | 2018-11-15 | 2019-01-18 | 江南大学 | A kind of method of fermenting and producing vitamin C precursor 2-keto-L-gulonic acid |
CN109234350B (en) * | 2018-11-15 | 2021-06-04 | 江南大学 | A kind of method for fermentation production of vitamin C precursor 2-keto-L-guronic acid |
CN114480237A (en) * | 2022-02-23 | 2022-05-13 | 江南大学 | Two-stage fermentation method for increasing yield of 2-KLG in gluconobacter |
CN114480236A (en) * | 2022-02-23 | 2022-05-13 | 江南大学 | A kind of construction method of Gluconobacter one-step bacteria chassis cell bank producing 2-KLG |
CN114480236B (en) * | 2022-02-23 | 2023-10-03 | 江南大学 | Construction method of one-step bacillus gluconate chassis cell bank for producing 2-KLG |
CN114480237B (en) * | 2022-02-23 | 2023-10-03 | 江南大学 | Two-stage fermentation method for improving yield of 2-KLG in gluconobacter |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102250822A (en) | Reconstruction method for producing Vitamin C precursor 2-keto-L-gulonic acid (2-KLG) with gluconobacter oxydans | |
CN114507613B (en) | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof | |
CN103484418A (en) | Gluconobacter oxydans gene engineering bacteria for producing 2-KLG and its application | |
CN102250821B (en) | Method for producing 2-keto-L-gulonic acid vitamin C precursor by modifying Escherichia coli | |
CN104762239B (en) | A kind of Klebsiella pneumoniae and application thereof and a method for producing 1,3-propanediol | |
CN113684163B (en) | Genetically engineered bacterium for improving lactoyl-N-tetraose yield and production method thereof | |
CN105647844A (en) | Recombinant bacteria using xylose to produce glycollic acid and building method and application of recombinant bacteria | |
CN102851252B (en) | Gluconobacter oxydans engineering bacterium for producing sorbic ketone in high yield mode and construction method thereof | |
CN104673736A (en) | Method for improving gluconobacter oxydans for producing 2-keto-L-gulconic acid | |
CN107217023A (en) | Multi-functional clostridium bifermentans and its application | |
CN104342463B (en) | A kind of preparation method of 1 cyanocyclohexanoic guanidine-acetic acid | |
CN116042425A (en) | Yeast engineering bacteria for producing patchouli alcohol and application thereof | |
CN103484417B (en) | Gluconobacter oxydans improving 2-KLG fermentation yield and application thereof | |
CN103710274B (en) | The genetic engineering bacterium that the outer output of pyruvic acid of a kind of born of the same parents improves and application thereof | |
CN110564580A (en) | Method for producing vinegar containing pyrroloquinoline quinone through microbial co-culture fermentation | |
CN105647846A (en) | Recombinant bacterium providing improved efficiency in convertive production of Alpha-phenylpyruvic acid | |
CN118344986A (en) | Bacterial strain producing beta-carotene using cheap nitrogen source and its construction method and application | |
CN107723300B (en) | Overexpression of CgGsh1 gene to improve 2-phenethyl alcohol tolerance and yield of glycerol-producing candida | |
CN105462868A (en) | Method for improving yield and production intensity of pyruvic acid | |
CN112501219B (en) | A method for producing lactic acid monomer by fermenting sucrose as raw material | |
CN115261361A (en) | Industrial fermentation method for generating hyaluronidase by recombinant pichia pastoris | |
CN101575588A (en) | Preparation technology for 2-keto -L-gulonic acid ferment strain | |
CN110951794B (en) | A kind of fermentation method for improving the production of glucaric acid by Saccharomyces cerevisiae engineering bacteria | |
WO2023000618A1 (en) | Bacillus xiaoxiensis and application thereof | |
CN102660571A (en) | Method for producing 1, 3 propylene glycol safely and highly efficiently |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111123 |